BEGIN:VCALENDAR
VERSION:2.0
PRODID:default
X-WR-TIMEZONE:Europe/Berlin
BEGIN:VTIMEZONE
TZID:Europe/Berlin
X-LIC-LOCATION:Europe/Berlin
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:DAYLIGHT
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:20211031T010000
END:STANDARD
BEGIN:STANDARD
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
DTSTART:20221030T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:48448ad24dd96b57554043646faafd1d
DTSTART;TZID=Europe/Berlin:20211215T150000
SEQUENCE:0
TRANSP:OPAQUE
URL:https://www.mdc-berlin.de/news/events/claudia-langenberg-what-can-blood
 -based-omics-deliver-clinical-translation
LOCATION:\, \,
SUMMARY:Claudia Langenberg - What can blood-based omics deliver for clinica
 l translation?
CLASS:PUBLIC
DESCRIPTION:Claudia Langenberg is Professor of Computational Medicine at th
 e\nBerlin Institute of Health at Charité (BIH) and MRC Investigator and\n
 Programme Leader at the MRC Epidemiology Unit at the University of\nCambri
 dge. She studied medicine in Münster\, Germany\, and moved to the\nUnited
  Kingdom to obtain her master’s and PhD in epidemiology and\ncomplete sp
 ecialist clinical training in public health medicine. After\nspending a ye
 ar at the University of California San Diego\, her\nresearch focused on th
 e genetic basis of metabolic control\, and her\nteam studies its effects o
 n health through integration of molecular\nwith clinical data in large-sca
 le patient and population-based\nstudies. Prof Langenberg has over 250 p
 ublications\, many in\nhigh-impact journals\, and is one of the most high
 ly cited scientists\nin her field.\n\nThe Berlin Center for Translational 
 Vascular Biomedicine\, jointly\nfounded by the Berlin Institute of Health 
 (BIH)\, Charité\nUniversitätsmedizin Berlin and the Max Delbrück Center
  for Molecular\nMedicine (MDC) in the Helmholtz Association\, represents a
 n\ninterdisciplinary scientific network with the pronounced aim to foster\
 ntranslation in the field of vascular biomedicine. It unites leading\nscie
 ntific knowledge with clinical expertise and thereby promotes the\ntransfe
 r of scientific insights to clinical use.\nPursuing its mission\, the Cent
 er initiated the Lecture Series\n“Vascular Networking” to invite disti
 nguished experts and promote\ninternational scientific exchange to both en
 rich the Berlin scientific\ncommunity and provide the foundation for new a
 nd visionary\ncollaborations.\nThe lecture series is conducted in an onlin
 e-format and attracts a\nbroad audience from the wider Berlin community. T
 he online event will\ncomprise a 45 min talk and a 15 min open discussion 
 followed by a 1\nhour closed exchange with 3-4 interested experts. These s
 lots are\nallocated on a first come first served basis. If you are interes
 ted\nplease indicate so on your event registration.\n
X-ALT-DESC;FMTTYPE=text/html:<p><span lang=\"EN-US\"><span><span><span>Clau
 dia Langenberg is Professor of Computational Medicine at the Berlin Instit
 ute of Health at Charité (BIH) and MRC Investigator and Programme Leader 
 at the MRC Epidemiology Unit at the University of Cambridge. She studied m
 edicine in Münster\, Germany\, and moved to the United Kingdom to obtain 
 her master’s and PhD in epidemiology and complete specialist clinical tr
 aining in public health medicine. After spending a year at the University 
 of California San Diego\, her research focused on the genetic basis of met
 abolic control\, and her team studies its effects on health through integr
 ation of molecular with clinical data in large-scale patient and populatio
 n-based studies. Prof Langenberg has over&nbsp\;</span></span></span></spa
 n><span><span><span><span>250&nbsp\;</span></span></span></span><span lang
 =\"EN-US\"><span><span><span>publications</span></span></span></span><span
 ><span><span><span>\, many in high-impact journals</span></span></span></s
 pan><span lang=\"EN-US\"><span><span><span>\, and is&nbsp\;</span></span><
 /span></span><span><span><span><span>one of the most highly cited scientis
 ts in her field</span></span></span></span><span lang=\"EN-US\"><span><spa
 n><span>.</span></span></span></span></p>\n\n<p>The Berlin Center for Tran
 slational Vascular Biomedicine\, jointly founded by the Berlin Institute o
 f Health (BIH)\, Charité Universitätsmedizin Berlin and the Max Delbrüc
 k Center for Molecular Medicine (MDC) in the Helmholtz Association\, repre
 sents an interdisciplinary scientific network with the pronounced aim to f
 oster translation in the field of vascular biomedicine. It unites leading 
 scientific knowledge with clinical expertise and thereby promotes the tran
 sfer of scientific insights to clinical use.<br>\nPursuing its mission\, t
 he Center initiated the Lecture Series “Vascular Networking” to invite
  distinguished experts and promote international scientific exchange to bo
 th enrich the Berlin scientific community and provide the foundation for n
 ew and visionary collaborations.<br>\nThe lecture series is conducted in a
 n online-format and attracts a broad audience from the wider Berlin commun
 ity. The online event will comprise a 45 min talk and a 15 min open discus
 sion followed by a 1 hour closed exchange with 3-4 interested experts. The
 se slots are allocated on a first come first served basis. If you are inte
 rested please indicate so on your event registration.</p>
DTSTAMP:20240529T172227Z
END:VEVENT
END:VCALENDAR